澳大利亚竞争与消费者委员会（ACCC）于7月17日宣布，将对Zoetis Inc.收购纽尔真检测（Neogen Corp）旗下基因组学业务的交易进行第二阶段审查。监管机构表示，目前尚未就相关问题达成最终结论，将在下一阶段继续深入评估此项收购案。
ACCC在声明中特别指出，委员会正在审慎考量Zoetis通过此次交易获取澳大利亚境内更大量牛群遗传数据可能带来的竞争影响。这一数据获取途径的变化，被视为评估交易对市场竞争效应的关键因素之一。
根据ACCC的安排，针对此项收购的第二阶段审查通知已正式发布。相关利益方被邀请在7月31日前提交意见书，以回应监管机构提出的审查事项。此举旨在更全面地收集市场反馈，为最终审查决定提供依据。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.